MedPath

AZAD Pharma AG

🇨🇭Switzerland
Ownership
Private
Employees
-
Market Cap
-
Website
https://www.azad.ch

Clinical Trials

9

Active:5
Completed:4

Trial Phases

2 Phases

Phase 1:6
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Phase 1
6 (85.7%)
Not Applicable
1 (14.3%)

Bioequivalence Study Comparing Single Dose of Ferrinemia® Injection With a Single Dose of Venofer® Injection in Healthy Male Volunteers

Phase 1
Completed
Conditions
Heathy Volunteers
Interventions
Drug: Ferrinemia
First Posted Date
2017-03-28
Last Posted Date
2018-07-05
Lead Sponsor
Azad Pharma AG
Target Recruit Count
48
Registration Number
NCT03093883
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

Bioequivalence Study With Pharmacokinetic Endpoints, Comparing a Single Dose of Iron Sucrose Azad Injection of Azad Pharma Corporation (AG), With a Single Dose of Venofer® Injection of Vifor Corporation (AG) in Healthy Adult Volunteers

Phase 1
Completed
Conditions
Healthy Volunteers
Interventions
First Posted Date
2015-03-18
Last Posted Date
2015-10-02
Lead Sponsor
Azad Pharma AG
Target Recruit Count
30
Registration Number
NCT02391181
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.